CML stem cells: evasion for better invasion

被引：2
|
作者：
Nicolini, Franck Emmanuel [1 ,2 ]
机构：
[1] Ctr Hosp Lyon Sud, Pierre Benite, France
[2] Ctr Leon Berard, Lyon, France
来源：
BLOOD | 2017年 / 129卷 / 02期
关键词：
CHRONIC MYELOID-LEUKEMIA; PEGINTERFERON ALPHA-2A; MOLECULAR RESPONSE; IMATINIB; MULTICENTER; INTERFERON; THERAPY;
D O I：
10.1182/blood-2016-11-750554
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：141 / 142
页数：4
相关论文
共 50 条
  • [1] Immune evasion by cancer stem cells
    Tsuchiya, Hiroyuki
    Shiota, Goshi
    REGENERATIVE THERAPY, 2021, 17 : 20 - 33
  • [2] APPROACHES TO ERADICATE CML STEM CELLS
    Holyoake, Tessa
    EXPERIMENTAL HEMATOLOGY, 2012, 40 (08) : S4 - S4
  • [3] Molecular pathways to CML stem cells
    Rice, Kristen N.
    Jamieson, Catriona H. M.
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2010, 91 (05) : 748 - 752
  • [4] Molecular pathways to CML stem cells
    Kristen N. Rice
    Catriona H. M. Jamieson
    International Journal of Hematology, 2010, 91 : 748 - 752
  • [5] Biology of CML stem cells.
    Eaves, CJ
    EXPERIMENTAL HEMATOLOGY, 1996, 24 (09) : 92 - 92
  • [6] Latency and immune evasion of metastatic stem cells
    Massague, Joan
    CANCER RESEARCH, 2016, 76
  • [7] In Search of CML Stem Cells’ Deadly Weakness
    Francesca Pellicano
    Amy Sinclair
    Tessa L. Holyoake
    Current Hematologic Malignancy Reports, 2011, 6 : 82 - 87
  • [8] In Search of CML Stem Cells' Deadly Weakness
    Pellicano, Francesca
    Sinclair, Amy
    Holyoake, Tessa L.
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2011, 6 (02) : 82 - 87
  • [9] Better positioned in stem cells
    Cheng, Linzhao
    BLOOD, 2009, 114 (07) : 1285 - 1286
  • [10] Metastatic latency and immune evasion by cancer stem cells
    Massague, Joan
    CANCER RESEARCH, 2016, 76
12345